Mirum (MIRM) Banks on Livmarli Sales Despite Recent Setback
Mirum Pharmaceuticals, Inc. MIRM develops novel therapies for treating rare liver diseases affecting children and adults. The company’s lead product, Livmarli (maralixibat), an orally administered i...